Studies show that switching to generic versions of NTI drugs like warfarin, phenytoin, and cyclosporine can lead to unstable blood levels, increased side effects, and serious health risks-even when generics are FDA-approved. What the data reveals about real-world outcomes.
Despite generics making up 90% of prescriptions, many doctors lack training on bioequivalence. Learn why medical education fails to build trust in generic drugs-and what actually changes prescribing habits.
Clinical outcomes data shows generic drugs are just as effective as brand-name medications for most conditions. Providers can confidently prescribe generics, knowing they meet strict FDA standards and save patients significant costs without compromising care.